Abiopharma

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference

Mainz Biomed Provides Review of 2025 Highlights

VYNE Therapeutics Updates for 01/05/2026

Abbotts new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning

Integer Holdings Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before February 9, 2026 to Discuss Your Rights - ITGR

PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)